Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
June 19, 2026
Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
June 1, 2026
Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results
May 29, 2026
Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week
May 28, 2026
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
May 28, 2026
Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
May 26, 2026
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
May 25, 2026
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
May 24, 2026
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
May 20, 2026
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results
May 19, 2026